Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZIMMER BIOMET HOLDINGS, INC.

(ZBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Zimmer Biomet : Needham Lowers PT for Zimmer Biomet Holdings to $187 From $202 Given Impact on Elective Procedures Amid Delta Variant Wave, Maintains Strong Buy

09/27/2021 | 02:51pm EST


ę MT Newswires 2021
All news about ZIMMER BIOMET HOLDINGS, INC.
11/24ZIMMER BIOMET HOLDINGS, INC. : Entry into a Material Definitive Agreement, Creation of a D..
AQ
11/24NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
11/23Argus Downgrades Zimmer Biomet Holdings to Hold From Buy
MT
11/18ZIMMER BIOMET HOLDINGS, INC. : Entry into a Material Definitive Agreement, Financial State..
AQ
11/18Zimmer Biomet to Present at Evercore ISI's 4th Annual HealthCONx Conference
PR
11/17Zimmer Biomet to Seek Acquisitions
CI
11/16Zimmer Biomet Keeps Quarterly Cash Dividend at $0.24 a Share, Payable Jan. 31 to Shareh..
MT
11/16Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2021
PR
11/16Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2021, Payable on or Ab..
CI
11/15ZIMMER BIOMET : Announces Cash Tender Offers for Certain Outstanding Debt Securities - For..
PU
More news
Analyst Recommendations on ZIMMER BIOMET HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2021 7 877 M - -
Net income 2021 839 M - -
Net Debt 2021 6 446 M - -
P/E ratio 2021 32,1x
Yield 2021 0,76%
Capitalization 26 243 M 26 243 M -
EV / Sales 2021 4,15x
EV / Sales 2022 3,82x
Nbr of Employees 20 000
Free-Float 66,8%
Chart ZIMMER BIOMET HOLDINGS, INC.
Duration : Period :
Zimmer Biomet Holdings, Inc. Technical Analysis Chart | ZBH | US98956P1021 | MarketScreener
Technical analysis trends ZIMMER BIOMET HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 125,62 $
Average target price 169,29 $
Spread / Average Target 34,8%
EPS Revisions
Managers and Directors
Bryan C. Hanson Chairman, President & Chief Executive Officer
Suketu P. Upadhyay Chief Financial Officer & Executive Vice President
Zeeshan Tariq Chief Information Officer & Senior Vice President
Nitin Goyal Chief Science, Technology & Innovation Officer
Ivan Tornos Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
ZIMMER BIOMET HOLDINGS, INC.-18.48%26 243
ABBOTT LABORATORIES14.97%222 592
MEDTRONIC PLC-5.20%149 347
BECTON, DICKINSON AND COMPANY-2.05%69 611
HOYA CORPORATION27.96%59 428
DEXCOM, INC.60.11%57 374